Research & Development
Kidney Disease: Page 2
Electronic health records make case for more kidney function testing
The study included EHRs for 244,540 adult patients treated in the Kaiser Permanente Southern California (KPSC) integrated healthcare delivery system. The researchers found that 58% of patients did not get timely follow-up for incidental abnormal results on estimated glomerular filtration rate (eGFR) tests. This falls far short of expert recommendations for a repeat creatinine test after 90 days to check for chronic kidney disease, reported the team led by Kim Danforth, an epidemiologist and health services researcher at KPSC.
July 16, 2019
RenalytixAI kidney disease blood test gets CPT code
The company expects that the new CPT Proprietary Laboratory Analyses (PLA) code -- 0105U -- will help the U.S. rollout of its lead product enabled by artificial intelligence (AI). A Medicare payment rate for the new code will be developed through the 2019 Clinical Laboratory Fee Schedule process, and RenalytixAI expects that this will take effect at the beginning of 2020.
June 30, 2019
Researchers link protein group to end-stage renal disease
Researchers found that a group of 17 circulating inflammatory proteins were consistently associated with a patient's progression to end-stage renal disease. They believe that the protein group, called the kidney risk inflammatory signature (KRIS), could alert physicians to the chance that a diabetic patient's disease is at risk of progressing.
April 22, 2019
Labcorp to pay $19M to settle kickback, false claims lawsuit
Vaccine effectiveness against Omicron variants may change over time
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
In pilot study, liquid biopsy test differentiates between localized and metastatic cancer to inform tailored treatment
Deepcell releases single-cell morphology data sets at AGBT general meeting
Siemens Healthineers, Unilabs ink 200-million euro agreement
Page 2 of 2